SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4v30'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1P93_D_DEXD4999_2
(GLUCOCORTICOID
RECEPTOR)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		4 / 5 LEU A  67
TRP A  36
LEU A 118
GLN A  29
 None
 1.46A 1p93D-4v30A:
undetectable		 1p93D-4v30A:
17.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2LH8_A_VIBA1_1
(MAJOR PRION PROTEIN)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		4 / 6 PRO A 107
HIS A 100
ASP A  84
TYR A  83
 None
 1.15A 2lh8A-4v30A:
undetectable		 2lh8A-4v30A:
16.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CI1_B_EF2B1429_1
(PROTEIN CEREBLON)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		6 / 10 ASN A  50
PRO A  51
SER A  78
TRP A  79
TRP A  85
TRP A  99
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.0A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
 0.40A 4ci1B-4v30A:
0.0		 4ci1B-4v30A:
16.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CI2_B_LVYB1429_1
(PROTEIN CEREBLON)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		6 / 9 ASN A  50
PRO A  51
SER A  78
TRP A  79
TRP A  85
TRP A  99
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.0A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
 0.42A 4ci2B-4v30A:
0.0		 4ci2B-4v30A:
16.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CI3_B_Y70B1429_1
(PROTEIN CEREBLON)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		6 / 10 ASN A  50
PRO A  51
SER A  78
TRP A  79
TRP A  85
TRP A  99
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.0A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
 0.40A 4ci3B-4v30A:
0.0		 4ci3B-4v30A:
16.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4TZ4_C_LVYC502_1
(PROTEIN CEREBLON)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		6 / 9 ASN A  50
PRO A  51
SER A  78
TRP A  79
TRP A  85
TRP A  99
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.0A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
 0.51A 4tz4C-4v30A:
0.0		 4tz4C-4v30A:
16.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4V2Y_A_EF2A151_1
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		7 / 7 ASN A  50
PRO A  51
PHE A  77
TRP A  79
TRP A  85
TRP A  99
TYR A 101
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
LVY  A 151 (-4.7A)
 0.10A 4v2yA-4v30A:
24.1		 4v2yA-4v30A:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4V2Y_B_EF2B151_1
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		7 / 7 ASN A  50
PRO A  51
PHE A  77
TRP A  79
TRP A  85
TRP A  99
TYR A 101
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
LVY  A 151 (-4.7A)
 0.27A 4v2yB-4v30A:
22.6		 4v2yB-4v30A:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4V2Y_C_EF2C151_1
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		7 / 7 ASN A  50
PRO A  51
PHE A  77
TRP A  79
TRP A  85
TRP A  99
TYR A 101
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
LVY  A 151 (-4.7A)
 0.74A 4v2yC-4v30A:
20.0		 4v2yC-4v30A:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4V2Z_A_Y70A151_1
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		7 / 7 ASN A  50
PRO A  51
PHE A  77
TRP A  79
TRP A  85
TRP A  99
TYR A 101
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
LVY  A 151 (-4.7A)
 0.11A 4v2zA-4v30A:
24.2		 4v2zA-4v30A:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4V2Z_B_Y70B151_1
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		8 / 8 ASN A  50
PRO A  51
MET A  54
PHE A  77
TRP A  79
TRP A  85
TRP A  99
TYR A 101
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
None
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
LVY  A 151 (-4.7A)
 0.28A 4v2zB-4v30A:
22.6		 4v2zB-4v30A:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4V2Z_C_Y70C151_1
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		8 / 8 ASN A  50
PRO A  51
PHE A  56
PHE A  77
TRP A  79
TRP A  85
TRP A  99
TYR A 101
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
None
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
LVY  A 151 (-4.7A)
 0.76A 4v2zC-4v30A:
19.9		 4v2zC-4v30A:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4V32_A_EF2A151_1
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		6 / 7 ASN A  50
PRO A  51
PHE A  77
TRP A  79
TRP A  85
TRP A  99
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
 0.13A 4v32A-4v30A:
24.0		 4v32A-4v30A:
99.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4V32_B_EF2B151_1
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		6 / 7 ASN A  50
PRO A  51
PHE A  77
TRP A  79
TRP A  85
TRP A  99
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
 0.30A 4v32B-4v30A:
22.6		 4v32B-4v30A:
99.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4V32_C_EF2C151_1
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		6 / 7 ASN A  50
PRO A  51
PHE A  77
TRP A  79
TRP A  85
TRP A  99
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
 0.77A 4v32C-4v30A:
19.6		 4v32C-4v30A:
99.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5AMH_A_EF2A151_1
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		7 / 7 ASN A  50
PRO A  51
PHE A  77
TRP A  79
TRP A  85
TRP A  99
TYR A 101
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
LVY  A 151 (-4.7A)
 0.47A 5amhA-4v30A:
22.0		 5amhA-4v30A:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5AMI_A_EF2A151_1
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		7 / 7 ASN A  50
PRO A  51
PHE A  77
TRP A  79
TRP A  85
TRP A  99
TYR A 101
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
LVY  A 151 (-4.7A)
 0.14A 5amiA-4v30A:
23.6		 5amiA-4v30A:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5AMI_B_EF2B151_1
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		8 / 8 ASN A  50
PRO A  51
PHE A  77
SER A  78
TRP A  79
TRP A  85
TRP A  99
TYR A 101
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.0A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
LVY  A 151 (-4.7A)
 0.26A 5amiB-4v30A:
22.3		 5amiB-4v30A:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5AMJ_A_EF2A151_1
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		7 / 7 ASN A  50
PRO A  51
PHE A  77
TRP A  79
TRP A  85
TRP A  99
TYR A 101
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
LVY  A 151 (-4.7A)
 0.17A 5amjA-4v30A:
23.4		 5amjA-4v30A:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5AMJ_B_EF2B151_1
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		7 / 7 ASN A  50
PRO A  51
PHE A  77
TRP A  79
TRP A  85
TRP A  99
TYR A 101
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
LVY  A 151 (-4.7A)
 0.25A 5amjB-4v30A:
22.3		 5amjB-4v30A:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5AMK_A_EF2A151_1
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		8 / 8 ASN A  50
PRO A  51
PHE A  56
PHE A  77
TRP A  79
TRP A  85
TRP A  99
TYR A 101
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
None
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
LVY  A 151 (-4.7A)
 0.56A 5amkA-4v30A:
22.2		 5amkA-4v30A:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5AMK_B_EF2B151_1
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		7 / 7 ASN A  50
PRO A  51
PHE A  77
TRP A  79
TRP A  85
TRP A  99
TYR A 101
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
LVY  A 151 (-4.7A)
 0.16A 5amkB-4v30A:
22.5		 5amkB-4v30A:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FQD_B_LVYB1438_1
(PROTEIN CEREBLON
CASEIN KINASE I
ISOFORM ALPHA)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		5 / 11 ASN A  50
PRO A  51
TRP A  79
TRP A  85
TRP A  99
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
 0.48A 5fqdB-4v30A:
0.0
5fqdC-4v30A:
0.0		 5fqdB-4v30A:
16.14
5fqdC-4v30A:
13.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FQD_E_LVYE1438_1
(PROTEIN CEREBLON
CASEIN KINASE I
ISOFORM ALPHA)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		6 / 12 ASN A  50
PRO A  51
SER A  78
TRP A  79
TRP A  85
TRP A  99
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.0A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
 0.44A 5fqdE-4v30A:
18.6
5fqdF-4v30A:
0.0		 5fqdE-4v30A:
16.14
5fqdF-4v30A:
13.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FQD_E_LVYE1438_1
(PROTEIN CEREBLON
CASEIN KINASE I
ISOFORM ALPHA)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		5 / 12 GLU A  76
SER A  78
TRP A  79
TRP A  85
TRP A  99
 None
LVY  A 151 (-4.0A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
 1.02A 5fqdE-4v30A:
18.6
5fqdF-4v30A:
0.0		 5fqdE-4v30A:
16.14
5fqdF-4v30A:
13.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5OH1_A_EF2A202_0
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		7 / 7 ASN A  50
PRO A  51
PHE A  77
TRP A  79
TRP A  85
TRP A  99
TYR A 101
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
LVY  A 151 (-4.7A)
 0.16A 5oh1A-4v30A:
24.1		 5oh1A-4v30A:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5OH1_B_EF2B202_0
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		7 / 7 ASN A  50
PRO A  51
PHE A  77
TRP A  79
TRP A  85
TRP A  99
TYR A 101
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
LVY  A 151 (-4.7A)
 0.36A 5oh1B-4v30A:
22.6		 5oh1B-4v30A:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5OH1_C_9UQC202_0
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		6 / 8 ASN A  50
PRO A  51
PHE A  77
TRP A  79
TRP A  99
TYR A 101
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.7A)
LVY  A 151 (-4.7A)
 1.00A 5oh1C-4v30A:
19.9		 5oh1C-4v30A:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5OH1_C_9UQC202_0
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		5 / 8 PRO A  51
TRP A  79
TRP A  85
TRP A  99
TYR A 101
 LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
LVY  A 151 (-4.7A)
 0.55A 5oh1C-4v30A:
19.9		 5oh1C-4v30A:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5OH3_A_9V2A202_0
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		7 / 7 ASN A  50
PRO A  51
PHE A  77
TRP A  79
TRP A  85
TRP A  99
TYR A 101
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
LVY  A 151 (-4.7A)
 0.15A 5oh3A-4v30A:
24.0		 5oh3A-4v30A:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5OH3_B_9V2B202_0
(CEREBLON ISOFORM 4)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		7 / 7 ASN A  50
PRO A  51
PHE A  77
TRP A  79
TRP A  85
TRP A  99
TYR A 101
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
LVY  A 151 (-4.7A)
 0.30A 5oh3B-4v30A:
23.0		 5oh3B-4v30A:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6H0F_B_Y70B502_0
(IKAROS (IKZF1)
PROTEIN CEREBLON)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		5 / 12 ASN A  50
PRO A  51
TRP A  79
TRP A  85
TRP A  99
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
 0.57A 6h0fB-4v30A:
19.6
6h0fC-4v30A:
undetectable		 6h0fB-4v30A:
21.09
6h0fC-4v30A:
16.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6H0F_E_Y70E502_0
(IKAROS (IKZF1)
PROTEIN CEREBLON)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		5 / 12 ASN A  50
PRO A  51
TRP A  79
TRP A  85
TRP A  99
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
 0.57A 6h0fE-4v30A:
0.0
6h0fF-4v30A:
undetectable		 6h0fE-4v30A:
21.09
6h0fF-4v30A:
16.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6H0F_H_Y70H502_0
(IKAROS (IKZF1)
PROTEIN CEREBLON)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		5 / 12 ASN A  50
PRO A  51
TRP A  79
TRP A  85
TRP A  99
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
 0.57A 6h0fH-4v30A:
0.0
6h0fI-4v30A:
undetectable		 6h0fH-4v30A:
21.09
6h0fI-4v30A:
16.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6H0F_K_Y70K502_0
(IKAROS (IKZF1)
PROTEIN CEREBLON)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		5 / 12 ASN A  50
PRO A  51
TRP A  79
TRP A  85
TRP A  99
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
 0.57A 6h0fK-4v30A:
0.0
6h0fL-4v30A:
undetectable		 6h0fK-4v30A:
21.09
6h0fL-4v30A:
16.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6H0G_B_Y70B502_0
(PROTEIN CEREBLON
ZINC FINGER PROTEIN
692)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		5 / 11 ASN A  50
PRO A  51
TRP A  79
TRP A  85
TRP A  99
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
 0.58A 6h0gB-4v30A:
0.0
6h0gC-4v30A:
undetectable		 6h0gB-4v30A:
21.09
6h0gC-4v30A:
14.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6H0G_E_Y70E502_0
(PROTEIN CEREBLON
ZINC FINGER PROTEIN
692)		 4v30 CEREBLON ISOFORM 4
(Magnetospirillum
gryphiswaldense) 		6 / 12 ASN A  50
PRO A  51
SER A  78
TRP A  79
TRP A  85
TRP A  99
 LVY  A 151 (-3.8A)
LVY  A 151 (-4.4A)
LVY  A 151 (-4.0A)
LVY  A 151 (-3.2A)
LVY  A 151 (-3.4A)
LVY  A 151 (-3.7A)
 0.53A 6h0gE-4v30A:
0.0
6h0gF-4v30A:
undetectable		 6h0gE-4v30A:
21.09
6h0gF-4v30A:
14.66